js","6773","static/chunks/6773-061975b7a13f2526.js","3763","static/chunks/3763-5031c38f7a5044a1.js","4777","static/chunks/4777-7fa79cea095b0267.js","5071","static/chunks/5071-1aaad1643fd0f3d9.js","8631","static/chunks/8631-6612905842e66f05.js","3956","static/chunks/3956-445a540d184d91db.js","7952","static/chunks/7952-ee4e3ac10fbedfda.js","512","static/chunks/512-bcb290eabed856c4.js","7759","static/chunks/7759-79303bb83414620d.js","5422","static/chunks/5422-29b2c0073e365b16.js","2507","static/chunks/2507-ee0144f0fb20ac76.js","8492","static/chunks/8492-f17ab3216fe361f9.js","2785","static/chunks/2785-116580b35f1bb322.js","8368","static/chunks/8368-438d4be7dd683dfc.js","9080","static/chunks/9080-238ac880c12fda6b.js","7072","static/chunks/7072-530245caea10a4c5.js","3192","static/chunks/3192-edaab38c2fdeb6ab.js","3077","static/chunks/3077-c474095a61bd66c9.js","8234","static/chunks/8234-bf699f647ee74353.js","4589","static/chunks/4589-5b05633819f33918.js","229","static/chunks/229-db5ac014176aaf5b.js","5458","static/chunks/app/dashboard/episodes/%5Bid%5D/page-249b9fb0028b9980.js"],"EpisodeRecommend"] 23:T72c,

The biotech community is reeling, fearful and furious about the fallout of tariff, FDA and NIH policies, according to BioCentury’s newly released Risk Sentiment survey. On the latest BioCentury This Week podcast, BioCentury’s editors discuss takeaways from the survey, which polled 328 biopharma stakeholders during April 10-14. The editors dissect the latest from Washington, including comments from FDA Commissioner Marty Makary on a new pathway for ultrarare drugs and his plans to reform advisory committee meetings, as well as last week’s executive order on drug pricing. They also discuss how China’s biotechs may have cracked one of the key

Ep. 290 - Biotech Survey Sees Tough Days Ahead. Plus: FDA, China Speed

BioCentury This Week